Risk stratification in emergency patients by copeptin

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Iversen, Kasper ^b   Gøtze, Jens P ^a   Dalsgaard, Morten ^b   Nielsen, Henrik ^c   Boesgaard, Søren ^a   Bay, Morten ^d   Kirk, Vibeke ^e   Nielsen, Olav W ^c   Køber, Lars ^a  

^a Rigshospitalet   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d FREDERIKSBERG HOSPITAL   (Denmark)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Biomarker; Inflammation; Mortality

Indexed keywords

COPEPTIN; BIOLOGICAL MARKER; GLYCOPEPTIDE;

AGED; ANAMNESIS; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BONE DISEASE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; EMERGENCY CARE; EMERGENCY PATIENT; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEMATOLOGIC DISEASE; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFECTION; ISCHEMIC HEART DISEASE; LIVER DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; MORTALITY; NEUROLOGIC DISEASE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; STRUCTURED INTERVIEW; ADULT; BLOOD; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; MIDDLE AGED; PROCEDURES; REGRESSION ANALYSIS; RISK;

ADULT; AGED; BIOLOGICAL MARKERS; EMERGENCY SERVICE, HOSPITAL; FEMALE; GLYCOPEPTIDES; HOSPITALIZATION; HUMANS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; MORTALITY; REGRESSION ANALYSIS; RISK; RISK ASSESSMENT; TRIAGE;

EID: 84902199777     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-12-80     Document Type: Article

References (37)

1. Hing E, Bhuiya F. Wait time for treatment in hospital emergency departments: 2009. NCHS Data Brief 2012, 102:1-8.
2. Guttmann A, Schull MJ, Vermeulen MJ, Stukel TA. Association between waiting times and short term mortality and hospital admission after departure from emergency department: population based cohort study from Ontario, Canada. BMJ 2011, 342:d2983. 10.1136/bmj.d2983, 3106148, 21632665.
3. Richardson DB. Increase in patient mortality at 10 days associated with emergency department overcrowding. Med J Aust 2006, 184:213-216.
4. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006, 52:112-119. 10.1373/clinchem.2005.060038, 16269513.
5. Katan M, Morgenthaler N, Widmer I, Puder JJ, Konig C, Muller B, Christ-Crain M. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett 2008, 29:341-346.
6. Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 2007, 115:2103-2110. 10.1161/CIRCULATIONAHA.106.685503, 17420344.
7. Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. J Am Coll Cardiol 2008, 52:266-272. 10.1016/j.jacc.2008.03.050, 18634981.
8. Smith JG, Newton-Cheh C, Almgren P, Struck J, Morgenthaler NG, Bergmann A, Platonov PG, Hedblad B, Engström G, Wang TJ, Melander O. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol 2010, 56:1712-1719. 10.1016/j.jacc.2010.05.049, 3005324, 21070922.
9. Katan M, Nigro N, Fluri F, Schuetz P, Morgenthaler NG, Jax F, Meckel S, Gass A, Bingisser R, Steck A, Kappos L, Engelter S, Müller B, Christ-Crain M. Stress hormones predict cerebrovascular re-events after transient ischemic attacks. Neurology 2011, 76:563-566. 10.1212/WNL.0b013e31820b75e6, 21228295.
10. Miller WL, Hartman KA, Grill DE, Struck J, Bergmann A, Jaffe AS. Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure. Heart 2012, 98:389-394. 10.1136/heartjnl-2011-300823, 3276775, 22194151.
11. Ostadal P, Kruger A, Zdrahalova V, Janotka M, Vondrakova D, Neuzil P, Prucha M. Blood levels of copeptin on admission predict outcomes in out-of-hospital cardiac arrest survivors treated with therapeutic hypothermia. Crit Care 2012, 16:R187. 10.1186/cc11671, 3682289, 23036303.
12. Potocki M, Reichlin T, Thalmann S, Zellweger C, Twerenbold R, Reiter M, Steuer S, Bassetti S, Drexler B, Stelzig C, Freese M, Winkler K, Haaf P, Balmelli C, Hochholzer W, Osswald S, Mueller C. Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction. Heart 2012, 98:558-565. 10.1136/heartjnl-2011-301269, 22337952.
13. Sabatine MS, Morrow DA, de Lemos JA, Omland T, Sloan S, Jarolim P, Solomon SD, Pfeffer MA, Braunwald E. Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease. Circulation 2012, 125:233-240. 10.1161/CIRCULATIONAHA.111.063842, 3277287, 22179538.
14. De Marchis GM, Katan M, Weck A, Brekenfeld C, Mattle HP, Buhl D, Müller B, Christ-Crain M, Arnold M. Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: The CoRisk Study. Int J Stroke 2013, 8:214-218. 10.1111/j.1747-4949.2011.00762.x, 22336226.
15. De Marchis GM, Katan M, Weck A, Fluri F, Foerch C, Findling O, Schuetz P, Buhl D, El-Koussy M, Gensicke H, Seiler M, Morgenthaler N, Mattle HP, Mueller B, Christ-Crain M, Arnold M. Copeptin adds prognostic information after ischemic stroke: Results from the CoRisk study. Neurology 2013, 80:1278-1286. 10.1212/WNL.0b013e3182887944, 23468541.
16. Miller WL, Grill DE, Struck J, Jaffe AS. Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure. Am J Cardiol 2013, 111:880-885. 10.1016/j.amjcard.2012.11.053, 23276468.
17. Alehagen U, Dahlstrom U, Rehfeld JF, Goetze JP. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. JAMA 2011, 305:2088-2095. 10.1001/jama.2011.666, 21610241.
18. Zweifel C, Katan M, Schuetz P, Siegemund M, Morgenthaler NG, Merlo A, Mueller B, Christ-Crain M. Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol 2010, 10:34. 10.1186/1471-2377-10-34, 2889932, 20504314.
19. Yu GF, Huang Q, Dai WM, Jie YQ, Fan XF, Wu A, Lv Y, Li YP, Yan XJ. Prognostic value of copeptin: one-year outcome in patients with traumatic brain injury. Peptides 2012, 33:164-169. 10.1016/j.peptides.2011.11.017, 22138140.
20. Zhang A, Li J, Li X, Song L, Li H. The prognostic value of copeptin for acute intracerebral hemorrhage patients. Exp Ther Med 2013, 5:467-470. 3570190, 23407763.
21. Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJ. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care 2008, 12:R11. 10.1186/cc6780, 2374597, 18252006.
22. Antonescu-Turcu AL, Tomic R. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations. Curr Opin Pulm Med 2009, 15:120-125. 10.1097/MCP.0b013e3283218603, 19532026.
23. Kruger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med 2010, 182:1426-1434. 10.1164/rccm.201003-0415OC, 20639437.
24. Maeder MT, Brutsche MH, Arenja N, Socrates T, Reiter M, Meissner J, Staub D, Morgenthaler NG, Bergmann A, Mueller C. Biomarkers and peak oxygen uptake in patients with chronic lung disease. Respiration 2010, 80:543-552. 10.1159/000319038, 20639623.
25. Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H, Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007, 28:219-226. 10.1097/SHK.0b013e318033e5da, 17515850.
26. Jochberger S, Dorler J, Luckner G, Mayr VD, Wenzel V, Ulmer H, Morgenthaler NG, Hasibeder WR, Dünser MW. The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit Care Med 2009, 37:476-482. 10.1097/CCM.0b013e3181957532, 19114902.
27. Jochberger S, Velik-Salchner C, Mayr VD, Luckner G, Wenzel V, Falkensammer G, Ulmer H, Morgenthaler N, Hasibeder W, Dünser MW. The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study. Intensive Care Med 2009, 35:489-497. 10.1007/s00134-008-1279-1, 18825368.
28. Luyt CE, Landivier A, Leprince P, Bernard M, Pavie A, Chastre J, Combes A. Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock. J Crit Care 2012, 27:524. e7-14.
29. Nickel CH, Ruedinger J, Misch F, Blume K, Maile S, Schulte J, Köhrle J, Hartmann O, Giersdorf S, Bingisser R. Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department. Acad Emerg Med 2011, 18:851-859. 10.1111/j.1553-2712.2011.01126.x, 21843221.
30. Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, Trawinski J, Boesgaard S, Aldershvile J. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 2003, 89:150-154. 10.1136/heart.89.2.150, 1767525, 12527664.
31. Pattaro C, Riegler P, Stifter G, Modenese M, Minelli C, Pramstaller PP. Estimating the glomerular filtration rate in the general population using different equations: effects on classification and association. Nephron Clin Pract 3013, 123:102-111.
32. Karl J, Borgya A, Gallusser A, Huber E, Krueger K, Rollinger W, Schenk J. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl 1999, 230:177-181.
33. Terzic D, Johansson-Fallgren AS, Ragnarsson O, Goetze JP, Hammarsten O. Evaluation of a sensitive copeptin assay for clinical measurement. Open Clin Chem J 2012, 5:21-26.
34. Keller T, Tzikas S, Zeller T, Czyz E, Lillpopp L, Ojeda FM, Roth A, Bickel C, Baldus S, Sinning CR, Wild PS, Lubos E, Peetz D, Kunde J, Hartmann O, Bergmann A, Post F, Lackner KJ, Genth-Zotz S, Nicaud V, Tiret L, Münzel TF, Blankenberg S. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010, 55:2096-2106. 10.1016/j.jacc.2010.01.029, 20447532.
35. Stolz D, Christ-Crain M, Morgenthaler NG, Leuppi J, Miedinger D, Bingisser R, Müller C, Struck J, Müller B, Tamm M. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 2007, 131:1058-1067. 10.1378/chest.06-2336, 17426210.
36. Jochberger S, Luckner G, Mayr VD, Wenzel V, Morgenthaler NG, Friesenecker BE, Hasibeder WR, Dünser MW. Course of vasopressin and copeptin plasma concentrations in a patient with severe septic shock. Anaesth Intensive Care 2006, 34:498-500.
37. Jochberger S, Zitt M, Luckner G, Mayr VD, Wenzel V, Ulmer H, Morgenthaler NG, Hasibeder WR, Dünser MW. Postoperative vasopressin and copeptin levels in noncardiac surgery patients: a prospective controlled trial. Shock 2009, 31:132-138. 10.1097/SHK.0b013e31817fd1d6, 18650776.